Therapy News and Research

RSS

2010 Quality Index Reports on Ontario's Cancer System

Wait times for cancer radiation treatment continued their decline across Ontario during 2009, despite a more than 10 per cent increase in the number of patients receiving treatment, according to the 2010 Cancer System Quality Index report issued today.

28 May 2010

Novel imaging system helps visualize and monitor cellular immune responses of transplanted tissue in real time

A group of "color-coded" laboratory mice are providing researchers with a novel way of tracking T-cells, enabling them to visualize and monitor the cellular immune responses of transplanted tissue in real time. The new imaging system is described in the June issue of Nature Medicine, which appears on-line this week.

28 May 2010

Helicobacter pylori's helical shape helps it colonize the stomach

The bacterium Helicobacter pylori, which lives in the human stomach and is associated with ulcers and gastric cancer, is shaped like a corkscrew, or helix. For years researchers have hypothesized that the bacterium's twisty shape is what enables it to survive - and thrive - within the stomach's acid-drenched environment, but until now they have had no proof.

28 May 2010

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.

28 May 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

VIVUS, Inc. today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 inhibitor therapy being investigated for the treatment of erectile dysfunction, will be presented next Tuesday at the American Urological Association 2010 Annual Meeting in San Francisco, California.

28 May 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced its Final Results for the year ending December 31, 2009, and the availability of its 2009 annual report on its website.

28 May 2010

KCI receives 510(k) clearance to market V.A.C. Therapy System for treatment of VLUs

Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration to market its proprietary Vacuum Assisted Closure, or V.A.C. Therapy System, for the treatment of venous insufficiency ulcers, also known as venous leg ulcers.

28 May 2010

MicroStockProfit.com releases investment report on Cord Blood America

MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

28 May 2010

Research finding could lead to first-ever target for drug therapy for lymphedema

A genetic mutation for inherited lymphedema associated with lymphatic function has been discovered that could help create new treatments for the condition, say researchers at the University of Pittsburgh Graduate School of Public Health. Their findings are reported in the June issue of the American Journal of Human Genetics.

28 May 2010

Usage of assistive devices boosts orthopedic brace and supports market

Frost & Sullivan recently completed a study for the U.S. orthopedic braces and supports markets that provides an in-depth analysis of a range of orthopedic braces and supports, along with a comprehensive study of crucial market drivers, challenges and technology trends impacting U.S. braces and supports manufacturers today.

28 May 2010

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Physicians now have two safe and effective options to treat their patients at risk for stroke, says a researcher at Mayo Clinic who led a large, NIH-funded, national clinical trial testing surgery or use of a stent to open a blocked carotid artery.

28 May 2010

Aggressive treatment of anaplastic thyroid carcinoma increases survival: Study

Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago.

28 May 2010

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

An advanced type of cancer radiation is more successful than traditional radiation in avoiding "dry mouth" when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing the size of tumors, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality.

28 May 2010

NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and clinicians and other stakeholders to highlight opportunities and discuss advances in the stem cell field.

28 May 2010

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.

28 May 2010

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide, previously known as a "cardiac biomarker" in dialysis patients, is an important component of managing patients with kidney disease.

28 May 2010

New treatment benefits patients with advanced liver disease due to HCV infection: Researchers

Researchers at the UCLA Medical Center found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

28 May 2010

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

28 May 2010

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

The Children's Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital's Cancer Center has recently begun using proton treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children's Hospital in Penn Medicine's Perelman Center for Advanced Medicine.

28 May 2010

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.

28 May 2010

Therapy News and Research

2010 Quality Index Reports on Ontario's Cancer System

Novel imaging system helps visualize and monitor cellular immune responses of transplanted tissue in real time

Helicobacter pylori's helical shape helps it colonize the stomach

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

VIVUS to present phase 3 data on avanafil for treatment of ED at AUA 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

KCI receives 510(k) clearance to market V.A.C. Therapy System for treatment of VLUs

MicroStockProfit.com releases investment report on Cord Blood America

Research finding could lead to first-ever target for drug therapy for lymphedema

Usage of assistive devices boosts orthopedic brace and supports market

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Aggressive treatment of anaplastic thyroid carcinoma increases survival: Study

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

New treatment benefits patients with advanced liver disease due to HCV infection: Researchers

Amgen announces European approval of Prolia

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

Fenwal biomedical engineer receives prestigious Junior Investigator Award for research on photopheresis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News